Technology Center Sample Clauses

Technology Center. Except as otherwise provided herein, Provider shall provide Technology Center services for Client in accordance with the applicable terms and conditions set forth in Annex 2 to the standard set forth in the Technology Center Table described in Section 4.2 below ("Technology Center Table"). The Technology Center will be standing, powered and climate controlled twenty-four (24) hours a day, seven (7) days a week and three hundred sixty-five (365) days a year ("7x24x365"). Provider will monitor the climate in the Technology Center continuously. All power and cooling will be maintained at a level necessary to maintain the SLAs. Provider will monitor all critical electrical, HVAC, fire detection and fire protection equipment, and security systems at the Technology Center or NOC 7x24x365.
View SourceView Similar (2)
Technology Center. I authorize the following individuals to transport above participant due to illness, disruptive behavior, or non-arrival of caregiver (proof of identity may be required before participant will be released): 1. Name: Phone: Relationship: 2. Name:
View Source
Technology Center. They may be mailed to: E.O.C. Technology Center Attn: Senior Adult Day Services ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇. Choctaw, OK 73020 Payments are due by the 15th of each month. A late fee of $10.00 per week will be charged for balances not paid on time. A fee of $20.00 will be applied for returned checks. We also accept credit cards. When you contract with us for services, we secure meals, staff, and transportation, etc., for the participants. The participant or caregiver will be responsible for notifying the SADS before 8:30 a.m. in cases of unscheduled absences (illness, emergencies, etc.). Notification must be made by noon the day prior to a scheduled absence (doctor's appointment, vacation, etc.). Additional charges for meals and transportation not cancelled in a timely manner will be billed as follows: $5.00 for uncancelled meals.
View Source

Related to Technology Center

  • Telemedicine Services This plan covers clinically appropriate telemedicine services when the service is provided via remote access through an on-line service or other interactive audio and video telecommunications system in accordance with R.I. General Law § 27-81-1. Clinically appropriate telemedicine services may be obtained from a network provider, and from our designated telemedicine service provider. When you seek telemedicine services from our designated telemedicine service provider, the amount you pay is listed in the Summary of Medical Benefits. When you receive a covered healthcare service from a network provider via remote access, the amount you pay depends on the covered healthcare service you receive, as indicated in the Summary of Medical Benefits. For information about telemedicine services, our designated telemedicine service provider, and how to access telemedicine services, please visit our website or contact our Customer Service Department.

  • Innovation In order to make it easier for the municipality to implement innovations that can accelerate the pace of climate transition, Viable Cities will provide a competence network and process support, including by engaging other strategic innovation programmes in the ongoing development of Climate City Contract 2030, particu- larly in the areas of mobility, energy, built environment, the circular economy, health and digitalization. Based on the collaboration agreement on climate-smart mobility signed with the strategic innovation programme Drive Sweden, this area of collabo- ration will be further developed with both cities and government agencies, not least the Swedish Transport Administration.

  • Information Systems Acquisition Development and Maintenance a. Client Data – Client Data will only be used by State Street for the purposes specified in this Agreement.

  • Technology Transfer Subject to the terms of the Development Supply Agreement, as soon as reasonably practicable, but in no event later than the fifth (5th) anniversary of the Effective Date, Alnylam shall initiate a technology transfer to MedCo, or to its Third Party manufacturer(s) of Licensed Product, selected by MedCo and reasonably acceptable to Alnylam, of Alnylam Know-How that is reasonably necessary or useful for the Manufacture of the Licensed Product, and shall make available its personnel on a reasonable basis to consult with MedCo or such Third Party manufacturer(s) with respect thereto, all at MedCo’s expense, including the Costs reasonably incurred by Alnylam in connection with such technology transfer activities. MedCo shall reimburse Alnylam such Costs incurred with respect to such Manufacturing technology transfer within [***] days after receipt of an invoice therefor. Alnylam and its Affiliates shall keep complete and accurate records in sufficient detail to enable the payments payable hereunder to be determined. Alnylam shall not be required to perform technology transfer to more than one Third Party manufacturer for each stage of the Licensed Product supply chain (i.e., Bulk Drug Substance, Bulk Drug Product and Finished Product). Promptly after MedCo’s written request, Alnylam shall use Commercially Reasonable Efforts to assign to MedCo any manufacturing agreement between Alnylam and a Third Party that is solely related to the manufacture of Licensed Products. Such assignment shall be subject to the terms and conditions of such agreement, including any required consents of such Third Party and MedCo’s written agreement to assume all the obligations of Alnylam under such agreement to be undertaken after such assignment, but Alnylam shall remain solely responsible for its obligations under such agreement arising prior to such assignment. Except as provided in the immediately preceding sentence, MedCo shall be solely responsible for contracting with such Third Party manufacturer (and any other Third Party manufacture to whom Alnylam has initiated technology transfer as set forth in this Section 5.3) for the supply of such Licensed Product and Alnylam shall have no obligations under such agreement between MedCo and such Third Party manufacturer. Alnylam shall use Commercially Reasonable Efforts to obtain any such consent in a form reasonably acceptable to MedCo.

  • Science The content in the sequence of BSC 1010C and BSC 1011C is comparable to the standards for Biology 1 and therefore if both are completed may be used as preparation for the associated EOC.